Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.
Overview
- Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan
- Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan
- Center for Human Brain Resource Initiative (ChBRI), Niigata University, Niigata, Japan
- Gunma University, Maebashi, Japan
- Department of Omics and Systems Biology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
Abstract
Tauopathies are neurodegenerative disorders characterized by intracellular accumulation of abnormal tau encoded by MAPT, yet their molecular mechanisms remain incompletely understood. We aimed to identify proteomic signatures associated with the primary tauopathies corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP), as well as the secondary tauopathy Alzheimer’s disease (AD), and to characterize their interaction networks. Total homogenates from the specified cortical region of postmortem brains of AD (n = 4), CBD (n = 4), PSP (n = 4), and control (n = 4) subjects were analyzed by mass spectrometry (MS). Differentially expressed proteins were subjected to functional enrichment and protein–protein interaction (PPI) network analyses. Reproducibility was assessed using JESS-based western blotting (WB), and selected candidates were examined by immunohistochemistry (IHC) and single-nucleus RNA sequencing (snRNA-seq) to evaluate cell-type–specific transcriptomic profiles. In the four-group comparison, 859, 114, 6, and 1 proteins showed PFDR < 0.05, < 0.01, < 0.005, and < 0.001, respectively. Six proteins (AK3, ATP5PD, COX7C, PPA1, PREP, and UQCRC1) with PFDR < 0.005 formed a highly interconnected network enriched for mitochondrial pathways, including oxidative phosphorylation and respiratory electron transport. WB validation showed strong concordance for four proteins (AK3, PREP, PPA1, and ATP5PD). IHC confirmed neuronal expression of PPA1 and PREP and revealed prominent microglial PPA1 immunoreactivity in PSP brains. snRNA-seq provided complementary cell-type–specific transcriptomic alterations. These findings suggest mitochondria-associated molecular changes shared across primary and secondary tauopathies; however, given the exploratory nature of this study, these observations should be interpreted cautiously and considered hypothesis-generating, warranting further investigation.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in “Data availability statement”
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 15 authors, 8 keywords, 17 references.
Cite
This paper
Jannah, A. R., Hasegawa, M., Ham, J., Hara, N., Tsukie, T., Obinata, A., Kikuchi, M., Kasuga, K., Yamaguchi, H., Hamasaki, H., Tada, M., Kakita, A., Matsumoto, M., Miyashita, A., & Ikeuchi, T. (2026). Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations. Frontiers in molecular neuroscience, 19, 1815858. https://
BibTeX
@article{jannah2026mass,
author = {Jannah, Alfi Raudatil and Hasegawa, Mai and Ham, Jonathan and Hara, Norikazu and Tsukie, Tamao and Obinata, Ai and Kikuchi, Masataka and Kasuga, Kensaku and Yamaguchi, Haruyasu and Hamasaki, Hideomi and Tada, Mari and Kakita, Akiyoshi and Matsumoto, Masaki and Miyashita, Akinori and Ikeuchi, Takeshi},
title = {{Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations}},
journal = {Frontiers in molecular neuroscience},
year = {2026},
month = may,
volume = {19},
pages = {1815858},
publisher = {Frontiers Media SA},
issn = {1662-5099},
doi = {10.3389/
url = {https://
pmid = {42254865},
pmcid = {PMC13236917}
}
RIS
TY - JOUR
AU - Jannah, Alfi Raudatil
AU - Hasegawa, Mai
AU - Ham, Jonathan
AU - Hara, Norikazu
AU - Tsukie, Tamao
AU - Obinata, Ai
AU - Kikuchi, Masataka
AU - Kasuga, Kensaku
AU - Yamaguchi, Haruyasu
AU - Hamasaki, Hideomi
AU - Tada, Mari
AU - Kakita, Akiyoshi
AU - Matsumoto, Masaki
AU - Miyashita, Akinori
AU - Ikeuchi, Takeshi
TI - Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations
T2 - Frontiers in molecular neuroscience
J2 - Front Mol Neurosci
PY - 2026
DA - 2026/
VL - 19
SP - 1815858
SN - 1662-5099
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations",
"container-title": "Frontiers in molecular neuroscience",
"author": [
{
"family": "Jannah",
"given": "Alfi Raudatil"
},
{
"family": "Hasegawa",
"given": "Mai"
},
{
"family": "Ham",
"given": "Jonathan"
},
{
"family": "Hara",
"given": "Norikazu"
},
{
"family": "Tsukie",
"given": "Tamao"
},
{
"family": "Obinata",
"given": "Ai"
},
{
"family": "Kikuchi",
"given": "Masataka"
},
{
"family": "Kasuga",
"given": "Kensaku"
},
{
"family": "Yamaguchi",
"given": "Haruyasu"
},
{
"family": "Hamasaki",
"given": "Hideomi"
},
{
"family": "Tada",
"given": "Mari"
},
{
"family": "Kakita",
"given": "Akiyoshi"
},
{
"family": "Matsumoto",
"given": "Masaki"
},
{
"family": "Miyashita",
"given": "Akinori"
},
{
"family": "Ikeuchi",
"given": "Takeshi"
}
],
"container-title-short":
"volume": "19",
"page": "1815858",
"DOI": "10.3389/
"PMID": "42254865",
"PMCID": "PMC13236917",
"ISSN": "1662-5099",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
22
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.mcpro.2025.101458 [code]
- Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies.Journal: Molecular & cellular proteomics : MCPIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references
- [2] doi:10.1038/s41593-024-01829-7
- In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds.Journal: Nature neuroscienceIn common: Alzheimer's / dementia, cellular / molecular, 2 references
- [3] doi:10.1038/s41586-025-09662-z [code]
- Lymphoid gene expression supports neuroprotective microglia function.Journal: NatureIn common: Alzheimer's / dementia, cellular / molecular, 3 references
- [4] doi:10.1038/s44319-024-00362-9
- Schizophrenia-related Xpo7 haploinsufficiency leads to behavioral and nuclear transport pathologies.Journal: EMBO reportsIn common: genetics / omics, cellular / molecular, 3 references
- [5] doi:10.3389/fnins.2024.1502246 [code]
- The cellular and extracellular proteomic signature of human dopaminergic neurons carrying the LRRK2 G2019S mutation.Journal: Frontiers in neuroscienceIn common: genetics / omics, cellular / molecular, 3 references
- [6] doi:10.1186/s13024-025-00817-0
- Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies.Journal: Molecular neurodegenerationIn common: histology / microscopy, other, Alzheimer's / dementia, 2 other categories, 1 reference
- [7] doi:10.1038/s44320-024-00050-9 [code]
- µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics.Journal: Molecular systems biologyIn common: other, genetics / omics, cellular / molecular, 2 references
- [8] doi:10.1186/s12974-025-03470-y
- Inflammation-induced lysosomal dysfunction in human iPSC-derived microglia is exacerbated by APOE 4/
4 genotype. Journal: Journal of neuroinflammationIn common: Alzheimer's / dementia, genetics / omics, cellular / molecular, 2 references - [9] doi:10.1167/iovs.66.15.4
- Presynaptic Changes in Mouse Rod Photoreceptors During Early Retinitis Pigmentosa.Journal: Investigative ophthalmology & visual scienceIn common: histology / microscopy, genetics / omics, cellular / molecular, 2 references
- [10] doi:10.1186/s13229-026-00716-1
- Nitric oxide inhibition ameliorates cortical proteomic changes in the Cntnap2&
lt;sup& gt;-/ -& lt;/ sup& gt; and Shank3& lt;sup& gt;Δ4-22& lt;/ sup& gt; mouse models of autism spectrum disorder. Journal: Molecular autismIn common: other, genetics / omics, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
